key: cord-0031075-bp9jmq7e
authors: Vammen, Lauge; Munch Johannsen, Cecilie; Magnussen, Andreas; Povlsen, Amalie; Riis Petersen, Søren; Azizi, Arezo; Løfgren, Bo; Andersen, Lars W.; Granfeldt, Asger
title: Cardiac Arrest in Pigs With 48 hours of Post‐Resuscitation Care Induced by 2 Methods of Myocardial Infarction: A Methodological Description
date: 2021-12-02
journal: J Am Heart Assoc
DOI: 10.1161/jaha.121.022679
sha: aa08b6abad6d9bf7dfb65c734f49eb291f31b326
doc_id: 31075
cord_uid: bp9jmq7e

BACKGROUND: Systematic reviews have disclosed a lack of clinically relevant cardiac arrest animal models. The aim of this study was to develop a cardiac arrest model in pigs encompassing relevant cardiac arrest characteristics and clinically relevant post‐resuscitation care. METHODS AND RESULTS: We used 2 methods of myocardial infarction in conjunction with cardiac arrest. One group (n=7) had a continuous coronary occlusion, while another group (n=11) underwent balloon‐deflation during arrest and resuscitation with re‐inflation after return of spontaneous circulation. A sham group was included (n=6). All groups underwent 48 hours of intensive care including 24 hours of targeted temperature management. Pigs underwent invasive hemodynamic monitoring. Left ventricular function was assessed by pressure‐volume measurements. The proportion of pigs with return of spontaneous circulation was 43% in the continuous infarction group and 64% in the deflation‐reinflation group. In the continuous infarction group 29% survived the entire protocol while 55% survived in the deflation‐reinflation group. Both cardiac arrest groups needed vasopressor and inotropic support and pressure‐volume measurements showed cardiac dysfunction. During rewarming, systemic vascular resistance decreased in both cardiac arrest groups. Median [25%;75%] troponin‐I 48 hours after return of spontaneous circulation, was 88 973 ng/L [53 124;99 740] in the continuous infarction group, 19 661 ng/L [10 871;23 209] in the deflation‐reinflation group, and 1973 ng/L [1117;1995] in the sham group. CONCLUSIONS: This article describes a cardiac arrest pig model with myocardial infarction, targeted temperature management, and clinically relevant post‐cardiac arrest care. We demonstrate 2 methods of inducing myocardial ischemia with cardiac arrest resulting in post‐cardiac arrest organ injury including cardiac dysfunction and cerebral injury.

infarction was only used in 2% of all studies. 2 The same review found, related to post-resuscitation care, that only 13% used organ-supportive measures, 4% targeted temperature management (TTM), and for the large animal models, the median post-resuscitation observation time was merely 4 hours. 2 Hence, there is an unmet need for clinically relevant large-animal cardiac arrest models to make sure that promising interventions are rigorously tested before translation into clinical studies.

There is a growing number of randomized clinical trials testing cardiac arrest interventions. 6 Despite this, only a minority of pre-clinically tested pharmacological interventions actually advance to clinical testing and experimental positive results often translate unsuccesfully. 7 If the quality of results from preclinical studies could be improved, this could increase the likelihood of translation of positive results to clinical trials. Conducting high quality, clinically relevant experimental animal research is therefore of key importance.

The aim of this study was to develop a cardiac arrest pig model encompassing clinically relevant features with regards to induction method, resuscitation, and post-cardiac arrest intensive care.

The study was approved by the Danish Animal Experiments Inspectorate (License number: 2019-15-0201-01647) and conducted and reported in accordance with the ARRIVE 8 and Utstein-Style 9 guidelines. The data that support the findings of this study are available from the corresponding author upon reasonable request.

Female crossbred Landrace/Yorkshire/Duroc pigs (40 kg) were fasted overnight with free access to water.

Each pig underwent myocardial infarction and cardiac arrest or sham-procedure. We initiated the experiments with a continuous myocardial infarction protocol (AMI-Cont group) and later included a group with an intermediary coronary reperfusion period before cardiac arrest (AMI-Int group, see Experimental Protocol paragraph). The sham group was subjected to the same procedures and treatments as the cardiac arrest groups except balloon inflation in the left anterior descending artery, cardiac arrest, and resuscitation (see Figure 1 ). Following resuscitation, the animals were kept anesthetized and mechanically ventilated for 48 hours and received post-cardiac arrest care including TTM for 24 hours. Cerebral data are presented in a separate publication to allow for a clear description of the core methodology in the current paper. A priori, we decided to include data from all pigs up until the pig was euthanized, either because of it reaching the end of protocol or premature death (eg, unsuccessful resuscitation or post-cardiac arrest organ failure). Pigs were a priori excluded if they presented with consistent mean arterial blood pressures (MAP) <65 mm Hg or mean arterial pulmonary pressure >25 mm Hg at baseline. Animals were allocated to the 3 groups at the discretion of the primary investigator in a non-randomized order and there was no blinding.

What Is New?

• This large animal model incorporates myocardial infarction, the most prevalent etiology to cardiac arrest, realistic resuscitative efforts, and clinically relevant long-term post-cardiac arrest intensive care. • By integrating clinically relevant measures into preclinical testing, we hope to decrease the translational gap that currently exists.

What Are the Clinical Implications?

• A more thorough testing of interventions might result in fewer futile clinical trials being conducted. 

Anesthesia was induced by ketamine (6.25 mg/kg), midazolam (0.625 mg/kg), and atropine (0.5 mg) and maintained with intravenous infusion of propofol (4.0-5.5 mg/kg per hour) and remifentanil (0.6-1.0 µg/kg per hour). See Data S1 for detailed anesthesia protocol and Figure S1 for infusion rates. Ringer lactate (2 mL/ kg per hour) with unfractionated heparin (18 IU/kg per hour) was administered to ensure normovolemia and prevent thromboembolic events throughout the protocol. An intravenous heparin bolus was administered before myocardial infarction instrumentation (5000 IU) and an intracoronary bolus before balloon occlusions (2500 IU). An additional 10 mL/kg fluid bolus was given at baseline. Mechanical ventilations with pressure-controlled volume guarantee (Datex Ohmeda S5, GE Healthcare, IL) were delivered with a tidal volume set at 8 mL/kg and a rate adjusted to an end-tidal CO 2 between 4.7 and 6.0 kPa. The fraction of inspired O 2 was adjusted to partial pressure of O 2 in arterial blood (PaO 2 ) between 20 and 25 kPa. Positive end-expiratory pressure was set to 5 cm H 2 O. The fraction of inspired O 2 and positive end-expiratory pressure were adjusted per protocol to optimize oxygenation (see Table S1 ).

For measurement of intracranial pressure (ICP), a burr hole was made in the skull and fitted with a bolt (Bolt Kit, Raumedic AG, Helmbrechts, Germany). After puncture of the dura mater a catheter (NEUROVENT-PTO, Raumedic AG, Helmbrechts, Germany) was inserted in the right parietal lobe parenchyma and connected to a monitor (MPR2 logO Datalogger, Raumedic AG, Helmbrechts, Germany). At baseline pigs were kept at normothermia (38.5±0.5 °C). A bladder catheter with thermometer was inserted.

Throughout the experimental protocol, pigs were monitored with end-tidal CO 2 , bladder temperature, urine output, saturation, one-lead electrocardiogram, heart rate, ICP, and invasive arterial blood pressure. A pulmonary artery catheter (Swan-Ganz CCOmbo catheter, Edwards Lifesciences, CA) was inserted to continuously measure pulmonary artery blood pressure, central venous pressure, cardiac output (CO), and mixed venous blood oxygen saturation. Correct catheter placement into a pulmonary artery branch was confirmed on fluoroscopy. Accumulated fluid balance was calculated as total urine output subtracted from accumulated amount of fluid treatment, anesthesia, and cardiovascular support. Systemic vascular resistance was calculated by the formula: ((MAP-central venous pressure)/CO)·80.

Pressure-volume (PV) measurements were conducted with an admittance PV-catheter (Transonic Systems Inc., NY) inserted in the left ventricle through the left carotid artery. Measurements were performed during apnea in triplicates at predetermined time points before and after cardiac arrest. Inferior vena AMI-Cont indicates cardiac arrest group with continuous myocardial infarction; AMI-Int, cardiac arrest group with reperfusion of coronary artery before cardiac arrest; CPR, cardiopulmonary resuscitation; LAD, left anterior descending artery; ROSC, return of spontaneous circulation; TTM, target temperature management; and VF, ventricular fibrillation. cava occlusion was performed to allow for both static and dynamic parameters. Data were collected with ADVantage (Transonic Systems Inc., NY) and analyzed in LabChart (ADInstruments, New Zealand). The PV system was calibrated for blood resistivity, stroke volume and heart type (normal). See Data S1 for intraobserver variability.

Arterial blood gasses (ABL 90 Flex Plus, Radiometer, Denmark), plasma EDTA and serum samples were collected at baseline and pre-defined time points after resuscitation. Blood samples were centrifuged, and supernatants stored at −80 °C for later analysis (see Data S1 for details).

After all monitoring equipment was established, a 30-minute stabilization period were performed.

Hearts were excised from the pigs after 48 hours of intensive care and scanned ex-vivo on a 1.5 T magnetic resonance system (Achieva DStream 1.5T, Phillips, Netherlands). Image analysis for measurement of infarct size was performed in Horos version 3.3.6 (MD, USA). See Data S1 and Figure S2 for details.

A 6F guiding catheter was placed in the ostium of the left main coronary artery via the left carotid artery. A balloon catheter (2-3×10 mm) was placed distal to the second diagonal branch. Occlusion was confirmed by a coronary angiography. After 5 minutes of occlusion, anesthesia was discontinued, and if ventricular fibrillation (VF) had not occurred after 10 minutes, it was electrically induced by a bipolar pacing wire (9 V DC current for 1-2 seconds) in the right ventricle. Cardiac arrest was confirmed by the presence of VF on the ECG and a swift drop in MAP, and the animal was disconnected from the ventilator. In the AMI-Cont group, the left anterior descending balloon remained inflated for 45 minutes continuously, throughout the VF period, resuscitation, and early post-return of spontaneous circulation (ROSC) period. In the AMI-Int group, the balloon was deflated after 10 minutes of occlusion, and 2 minutes after deflation VF was electrically induced. The balloon catheter was re-inflated 5 minutes after return of spontaneous circulation for another 35 minutes of myocardial ischemia (see Figure 1 ). Occlusion or reperfusion was confirmed by coronary angiographies.

After 7 minutes of untreated cardiac arrest, basic cardiopulmonary resuscitation was initiated with a 30:2 algorithm (mechanical chest compressions (LUCAS II, Jolife AB, Sweden) and bag ventilations) in accordance with European Resuscitation Council guidelines. 10 Basic cardiopulmonary resuscitation was followed by a rhythm check and subsequent biphasic 360 J defibrillation (Lifepak 20, Physio-Control, WA) if a shockable rhythm was present. Hereafter, advanced life support was started with continuous chest compressions and mechanical asynchronous ventilations. Rhythm check and subsequent shock was performed every 2 minutes. Adrenaline (0.02 mg/kg) was administered after the third and every other rhythm analysis. If in a shockable rhythm, a single bolus of amiodarone was administered after the third (5 mg/kg) and fifth (2.5 mg/kg) rhythm analyses. Advanced life support was continued until ROSC (defined as an organized rhythm with MAP >30 mm Hg lasting >1 minute) or until a total of 30 minutes of resuscitative efforts. See Data S1 for resuscitation details.

For details see Table S1 . In short, the following treatment goals for vital parameters were set according to post-resuscitation care guidelines 11 : partial pressure of CO 2 in arterial blood 4.7 to 6.0 kPa (alpha-stat management), arterial blood saturation (SaO 2 ) 94% to 98%, MAP >65 mm Hg, CO>2.0 L/min, mixed venous blood oxygen saturation>50%, blood glucose 4 to 10 mmol/L, and potassium 3.0 to 5.5 mmol/L. Relevant fluid (4 mL/ kg bolus, max 1 L/24 h), inotropic (dobutamine 0.1-15.0 µg/kg per min and adrenaline 0.01-1.00 µg/kg per min), and vasopressor (noradrenaline 0.01-1.00 µg/ kg per min and terlipressin 0.2-1.0 mg) support were administered to meet set treatment goals. Within the initial 60 minutes of ROSC, if noradrenaline was inadequate at maintaining MAP>65 mm Hg, repeated adrenaline boluses (0.1 mg/bolus) were administered. Arrhythmias were treated with defibrillation or amiodarone according to the post-resuscitation protocol. If MAP dropped below 30 mm Hg, advanced life support was initiated. Potassium homeostasis was upheld by K + supplement and furosemide and insulin/glucose infusions. Prophylactic cefuroxime (750 mg) was administered every 8 hours following ROSC. 12 Blood glucose control was achieved with insulin and glucose administrations. All pigs received 10 mL/h enteral nutrition via feeding tube. One hour after ROSC, TTM to 33 °C was started with a surface cooling device (Arctic Sun, Medivance Inc., CO). To allow for swift cooling, neuromuscular blockade with rocuronium was established and maintained until rewarmed to 36 °C. The target temperature was maintained for 24 hours. Rewarming rate was 0.5 °C/h until normothermia (38.5 °C). Active normothermia was ensured throughout the remainder of the experimental protocol. At the end of protocol, animals were euthanized with an intravenous injection of pentobarbital (120 mg/kg).

Normality was evaluated by qq-plots and histograms. The majority of outcome variables were non-normally distributed. Therefore, continuous data are presented as medians with 25% and 75% quartiles. Categorical data are presented as n (%). The present study was a method development experiment of purely descriptive nature and no sample size calculation was performed. Study data were collected using REDCap electronic data capture tools hosted at Aarhus University. 13 

A total of 25 pigs were included in this study. One pig in the sham group was excluded because of hypotension during baseline preparation and subsequent VF during pressure-volume measurements. The remaining 24 pigs were divided as follows: AMI-Cont=7, AMI-Int=11, and sham=6 ( Figure 2 ). Three animals underwent premature euthanasia: 1 pig in the sham group had major bleeding attributable to an accidental discontinuation of an arterial sheath at 5 hours; 1 pig in the AMI-Int group died because of a tension pneumothorax (necropsy confirmed) at 37 hours post-ROSC; and 1 pig in the AMI-Cont group died of cardiovascular collapse at the end of the protocol missing only magnetic resonance imaging data.

The Table 1 displays cardiac arrest and resuscitation parameters. In the AMI-Cont group 3 of 7 (43%) pigs achieved ROSC with 7 of 11 (64%) pigs in the AMI-Int group.

Bladder temperature is displayed in Table 2 and Figure 

Hemodynamic parameters are displayed in Figure 3 and Table 2 . Up until 24 hours post-ROSC, the sham group had higher MAP and CO in conjunction with a lower heart rate when compared with both cardiac arrest groups. In the AMI-Cont group, 3 of 3 animals received noradrenaline within the first hour after ROSC as did 5 of 7 animals in the AMI-Int group. The AMI-Cont group received a median amount of adrenaline support of 0.14 mg [0.00;7.60] during the first hour whereas the AMI-Int group received 0.02 mg [0.00;2.30]. The sham group received no cardiovascular support during the first hour. From the onset of rewarming, a sudden drop in systemic vascular resistance in the AMI-Cont group was observed; an effect that lasted throughout the rewarming phase. This was reflected by the need for incremental doses of cardiovascular support and an increase in CO when compared with the AMI-Int group ( Figure 4 , for graph of infusion rates see Figure S4 ). The AMI-Int group sustained systemic vascular resistance at the onset of rewarming but were also in need of increased doses of cardiovascular support. 

The low number of successfully resuscitated pigs in the AMI-Cont group and cardiovascular instability in this group precluded collection of dynamic parameters from all time points. The limited amount of data from the AMI-Cont group are provided in Figure S5 . Figure 5 displays dynamic PV measurements for the AMI-Int and sham groups. During the first 6 hours after ROSC, end-systolic pressure-volume relationship (ESPVR) and preload recruitable stroke work xaxis intercepts were preserved relative to baseline in the AMI-Int group compared with leftward shift in the sham group. Throughout the remainder of the observation period, ESPVR slope rose slightly in the AMI-Int group with simultaneous marked rightward shift of ESPVR x-axis intercept. No major differences were observed in preload recruitable stroke work parameters during this period. Table 3 shows all static PV parameters. Ejection fraction was generally lower in the 2 cardiac arrest groups after resuscitation, but similar between all groups at 48 hours post-ROSC. The time constant of isovolumetric relaxation increased in all 3 groups during TTM, albeit to higher levels in the sham group. Maximum rate of pressure development during contraction (dP/dt max ) and minimum rate of pressure development during relaxation (dP/dt min ) were similar at baseline in all 3 groups but dP/dt max was lower and dP/dt min higher at the end of protocol in the 2 cardiac arrest groups compared with the sham group. The AMI-Int and sham groups, developed similarly with ICP levels <25 mm Hg with no marked deviations over time. One exception is a single pig in the AMI-Int group, in where ICP rose to 46 mm Hg 48 hours after ROSC. In all 3 groups no differences were seen in NSE levels up until 6 hours after ROSC. At 12 hours after ROSC, NSE rose considerably in the 2 cardiac arrest groups, albeit to higher levels in the AMI-Cont group. Figure 7 shows markers of organ function and injury. Myocardial injury measured by troponin-I was higher in both cardiac arrest groups compared with sham group, with peak values occurring around 4 hours after successful resuscitation. Blood levels of troponin-I were higher during the entire post-ROSC phase in the AMI-Cont group compared with AMI-Int group. Creatinine levels after ROSC were higher in both cardiac arrest groups compared with the sham group. Elevated creatinine >100 µmol/L at 48 hours after ROSC were observed in 4 cardiac arrest animals (2 from each group) and this was associated with increased need of cardiovascular support. There was an early rise in alanine aminotransferase in the AMI-Cont group after resuscitation, however all 3 groups displayed a rise in alanine aminotransferase throughout the maintenance phase of cooling. Only in the sham group, alanine aminotransferase levels returned to baseline at 48 hours after ROSC. Creatine kinase was markedly elevated in both cardiac arrest groups after resuscitation when compared with sham group.

Infarct size measurement were performed in 1 AMI-Cont and 3 AMI-Int animals. The AMI-Cont animal had an infarct volume relative to left ventricular volume of 4.5% while the median percentage in the AMI-Int animals were 1.4% [0.5;3.9]. Table 4 shows parameters for pulmonary function throughout the protocol. All 3 groups demonstrated fairly similar ventilation and oxygenation parameters throughout the protocol, with a lower pressure of O 2 in arterial blood/fraction of inspired O 2 ratio at the end of protocol. This was most pronounced in the AMI-Cont group.

In this article, we provide a methodological description of a cardiac arrest model in pigs with concurrent myocardial infarction and a clinically relevant post-cardiac arrest intensive care period. We demonstrate 2 variations of myocardial infarction in conjunction with resuscitation resulting in different grades of hemodynamic instability and multi-organ injury.

No studies offer an exact list of etiologies of cardiac arrest, however, a collection of reports show that 56% to 73% of all out-of-hospital arrests are of cardiac cause. [14] [15] [16] Angiography and autopsy studies of out-ofhospital patients with cardiac arrest have shown that between 35% and 74% of patients have myocardial infarction as the likely cause of their cardiac arrest, [3] [4] [5] and it is therefore believed to be the most prevalent cause of out-of-hospital cardiac arrest. We used 2 methods of inducing myocardial injury. The AMI-Cont method has previously been used for testing intra-cardiac arrest interventions that might affect ROSC rates. 17, 18 If applied in conjunction with a long intensive care period, it is suitable for testing of interventions with a cardiac protective scope as seen in the 2 prior studies of myocardial infarction-induced cardiac arrest with long post-cardiac arrest intensive care periods. 19, 20 The AMI-Int group on the other hand, demonstrated less myocardial damage with the added benefit of increased ROSC rates compared with the AMI-Cont group. Based on this and combined with a less severe post-cardiac arrest syndrome phenotype makes it suitable for potential advancement into a survival model. The majority of patients with cardiac arrest receives post-resuscitation care for extended periods in the intensive care unit. 21 A number of myocardial infarctioninduced cardiac arrest studies have been conducted on pigs with long survival but with short intensive care periods. Observation periods range between 24, 22-26 72, 27, 28 or 96 hours. [29] [30] [31] The longest period of post-cardiac arrest intensive care was 4 hours. [27] [28] [29] [30] [31] [32] A consequence of awakening the animals shortly after resuscitation is that animals, which achieve initial ROSC but are cardiovascularly unstable in the early post-resuscitation phase might die during the observation period in the pen without an exact cause of death. In fact, 2 animals in our study (1 from each cardiac arrest group) received our maximum noradrenaline dosage (1 µg/kg per minute) and adrenaline support within the first 2 hours of ROSC, but both pigs survived until 48 hours with normal hemodynamic status, no inotropic support and in need of only low dose noradrenaline (<0.1 µg/kg per min).

The primary cause of death in successfully resuscitated out-of-hospital patients with cardiac arrest is Systemic ischemia-reperfusion injury results in multiorgan injury or even failure and by taking animals of supportive care in the early phase after resuscitation, the animals are of risk of dying from perhaps preventable causes (eg, arrhythmias, cardiovascular collapse, acute renal injury, acute respiratory distress, etc.). 34 A longer intensive care period makes organ supportive measures possible that might help animals survive until neurological examination similar to patients.

In the AMI-Int group, the rightward shifted ESPVR and preload recruitable stroke work x-axis intercepts when compared with sham animals, in conjunction with a lower ejection fraction, lower dP/dt max despite cardiovascular support all point towards decreased systolic function during the first 6 hours. Although there was a slight increase in the ESPVR slope in the AMI-Int group during the remainder of the intensive care period, the simultaneous marked rightward shift of ESPVR x-axis intercept indicates continuous depressed systolic function. 35 This is underlined by lower dP/dt max at 48 hours in both cardiac arrest groups when compared with the sham group. The effects of hypothermia on left ventricular function as observed in the sham group showed decreased diastolic function (increased time constant of isovolumetric relaxation and higher dP/dt min values) with simultaneous leftward shift in ESPVR, which confirms earlier findings. 36, 37 The leftward ESPVR shift was, however, restored to baseline levels during the maintenance and rewarming phases. The effect of hypothermia on diastolic function as measured by time constant of isovolumetric relaxation was abolished in both cardiac arrest groups, because of the increased catecholaminergic stimulus provided by the cardiovascular support. 38 Diastolic dysfunction because of cardiac arrest is signified by the higher dP/dt min values at 48 hours in both cardiac arrest groups compared with the sham group. Cardiac dysfunction is a main 34 and especially in a model of myocardial infarction as used in this study. Both troponin-I levels and magnetic resonance data confirm that a myocardial infarction was indeed induced in both cardiac arrest groups. Prior studies with a reperfusion-reocclusion approach to myocardial infarction induction have reported infarct sizes of 6% to 10% relative to left ventricular mass. [29] [30] [31] The smaller infarct sizes in our model can be assigned to the lower sensitivity of a non-contrast magnetic resonance scan relative to conventional methods for infarct size measurements. During rewarming, we observed a marked decrease in blood pressure with preserved CO in the cardiac arrest groups, which were treated mainly by incremental doses of vasopressors. Previous studies in pigs with ≥24 hours of TTM to 33 °C have all employed a method of electrically induced cardiac arrest without myocardial ischemia, and none of the studies have demonstrated a similar hemodynamic instability during rewarming. [39] [40] [41] The reasons for the sudden drop in systemic vascular resistance need further investigations but one possible explanation is that our model may represent a more severe phenotype of the postcardiac arrest syndrome than previous investigations.

Based on the NSE results, both cardiac arrest models included neuronal injury. The markedly higher NSE levels seen in the AMI-Cont group could be attributable to the 2 pigs in this group who had ICPs that were incompatible with a good neurological outcome. The AMI-Cont group had longer resuscitation times when compared with the AMI-Int group, which might have inflicted more cerebral injury. Furthermore, the greater cardiovascular instability and increased vasopressor usage in the AMI-Cont group, might have added secondary neurological injury. The relative and absolute increase in NSE values in the AMI-Int group is comparable with previous investigations of a similar myocardial infarction induced cardiac arrest models with intermittent reperfusion. 28, 29 Methodological Considerations

Although striving to adhere to the clinical setting, some aspects of the described model may be considered less clinically relevant: (1) VF was electrically induced, and (2) the myocardial infarction size was relatively small. We chose electrically induced VF to standardize the myocardial infarction period more uniformly to the cardiac arrest period. Furthermore, it is well known that spontaneously induced VF (even without underlying ischemia) elevates the defibrillation threshold relative to electrically induced VF. 42, 43 A larger myocardial infarction would have led to a higher proportion of spontaneously induced VF episodes but undoubtedly also more hemodynamically unstable pigs in the post-cardiac arrest phase. This could have been counteracted by using extra-corporeal membrane oxygenation in conjunction with conventional cardiopulmonary resuscitation. Previous investigations of cardiac arrest pig models with concomitant myocardial infarction have used extra-corporeal membrane oxygenation, however, all with relatively shorter post-ROSC observation periods. [44] [45] [46] Although the use of extra-corporeal membrane oxygenation is increasing, extracorporeal cardiopulmonary resuscitation is reserved to a small percentage of selected cardiac arrest cases, and our model serves as a general cardiac arrest model. With regards to TTM, we chose a 33 °C strategy as this was recommended by international guidelines at the initiation of the experiments, 11 and this has been the most common strategy in previous porcine cardiac arrest models. [39] [40] [41] Limitations Although we believe clinical relevance to be important for a better translation of results from the experimental to the clinical setting, one has to consider the increased variability introduced by intensive care, long-term anesthesia, and mechanical ventilation. These models do not necessarily represent many of the complexities observed in patients with cardiac arrest (out-of/in-hospital, witnessed/non-witnessed, shockable/non-shockable rhythm, etc.) and, in general this is difficult to obtain in an experimental setup. Furthermore, we only used female, young, and healthy animals without common comorbidities (eg, congestive heart failure, diabetes mellitus and renal disease), nor did the animals receive the chronic medications adhering to these diseases. 47 The low number of animals in each group is also a limitation but given the aim of the study, we wanted to include enough animals to allow a sufficient description of the methodology.

This study successfully describes the development of a cardiac arrest pig model, with myocardial infarction, TTM, and clinically relevant post-cardiac arrest care. We demonstrate 2 different methods of inducing myocardial ischemia together with cardiac arrest which results in post-cardiac arrest organ injury including cardiac dysfunction and cerebral injury.

Chest compressions were delivered at a frequency of 100 min -1 and a 50%/50% duty cycle allowing full passive recoil between compressions. The LUCAS piston was placed in the median line of the thorax with the inferior part of the piston just above the xiphoid process. The anterior defibrillator pad (Quik-Combo, Physio-Control, WA, USA) was placed on the anterior-lateral left hemi-thorax (corresponding to apex of the heart) and the posterior pad was placed on the posterior-lateral right hemi-thorax with the medial side juxta-positioned with the thoracic column. Mechanical ventilations during resuscitation was delivered in volume-controlled mode with FiO2 100 %, tidal volume 8 ml/kg, respiratory frequency at 10 per min, and PEEP 0 CM H2O. Upon ROSC, the ventilator was switched back to pressure-controlled with volume guarantee.

MR protocol Three-dimensional T1-weighted and T2-weighted imaging covering the entire heart was done. For the T1w images, a 3D spoiled gradient echo sequence with isotropic voxel size of 0.7 mm; TR/TE = 12 ms/5.3 ms; flip angle = 50°; 6 averages, and scan duration 29:54 minutes was used. For the T2w images, a 3D Fast Spin Echo (3DVIEW) sequence with isotropic voxel size of 0.7 mm; Echo Train Length = 141; TR/TE = 2,000 ms/327 ms; 6 averages, and scan duration 42:26 minutes was applied.

During images analysis, for each 0.7 mm slice the left ventricle myocardium area and infarct area was measured to calculate left ventricular myocardium volume, infarct size volume, and the ratio of infarct volume relative to left ventricular volume. • Pressure controlled with volume guarantee (PCV-VG) • Tidal volume = 8 ml/kg • Respiratory rate = 10-35 per min (adjusted to PaCO2) • FiO2 = 0.30 • PEEP = 5 cm H2O A sustained (>10 min) decrease in blood oxygen levels (SaO2) was intervened by first suctioning the tracheal tube. If insufficient, increase FiO2 (10 %) and PEEP (2 cm H2O), respectively, starting with the value furthest from initial values; if equidistant starting with PEEP. A sustained increase in oxygen levels was intervened on conversely. Lowest PEEP level at 5 cm H2O. Figure S5 . Dynamic PV-measurements for all three groups. At 30-42 hours after resuscitation only data from one animal in the AMI-Cont group exists, because PV measurements were impossible to perform due to cardiovascular instability in the remaining animals. ESPVR: end-systolic pressure-volume relationship, EDPVR: enddiatolic pressure-volume relationship, PRSW: preload-recruitable stroke work. 

−927

Animal models of cardiac arrest: a systematic review of bias and reporting. Resuscitation

Contemporary animal models of cardiac arrest: a systematic review

Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death

Immediate coronary angiography in survivors of out-ofhospital cardiac arrest

Out-of-hospital cardiac arrest: causes according to autopsy and electrocardiography -analysis of 781 patients with neither hospital care nor prescribed medication during the preceding two years

Adult post-cardiac arrest interventions: an overview of randomized clinical trials

Translation from animal studies of novel pharmacological therapies to clinical trials in cardiac arrest: a systematic review

The arrive guidelines 2.0: updated guidelines for reporting animal research

Utstein-style guidelines for uniform reporting of laboratory CPR research. A statement for healthcare professionals from a Task Force of the American Heart Association, the American College of Emergency Physicians, the American College of Cardiology, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Institute of Critical Care Medicine, the Safar Center for Resuscitation Research, and the Society for Academic Emergency Medicine. Writing group

European resuscitation council guidelines for resuscitation 2015: Section 2. Adult basic life support and automated external defibrillation

European resuscitation council and European Society of Intensive Care Medicine 2015 guidelines for post-resuscitation care

Prevention of early ventilator-associated pneumonia after cardiac arrest

The redcap consortium: building an international community of software platform partners

Epidemiology and outcomes from out-of-hospital cardiac arrests in England

Early cardiopulmonary resuscitation in out-of-hospital cardiac arrest

The epidemiology of out-of-hospital 'sudden' cardiac arrest

Intra-cardiopulmonary resuscitation hypothermia with and without volume loading in an ischemic model of cardiac arrest

Sodium nitroprusside enhanced cardiopulmonary resuscitation improves short term survival in a porcine model of ischemic refractory ventricular fibrillation

The effect of levosimendan on survival and cardiac performance in an ischemic cardiac arrest model -a blinded randomized placebo-controlled study in swine

Hypothermia and postconditioning after cardiopulmonary resuscitation reduce cardiac dysfunction by modulating inflammation, apoptosis and remodeling

Association of bystander interventions and hospital length of stay and admission to intensive care unit in out-of-hospital cardiac arrest survivors

Assisted ventilation during 'bystander' CPR in a swine acute myocardial infarction model does not improve outcome

Preshock cardiopulmonary resuscitation worsens outcome from circulatory phase ventricular fibrillation with acute coronary artery obstruction in swine

Predictors of resuscitation outcome in a swine model of VF cardiac arrest: a comparison of VF duration, presence of acute myocardial infarction and VF waveform

Early coronary revascularization improves 24h survival and neurological function after ischemic cardiac arrest. A randomized animal study

The ventricular fibrillation waveform approach to direct postshock chest compressions in a swine model of VF arrest

Outcomes of CPR in the presence of partial occlusion of left anterior descending coronary artery

Postresuscitation treatment with argon improves early neurological recovery in a porcine model of cardiac arrest

Duration of untreated cardiac arrest and clinical relevance of animal experiments: the relationship between the "no-flow" duration and the severity of post-cardiac arrest syndrome in a porcine model

Ventilation with argon improves survival with good neurological recovery after prolonged untreated cardiac arrest in pigs

Effect of mild hypercapnia on outcome and histological injury in a porcine post cardiac arrest model

A comparison of electrically induced cardiac arrest with cardiac arrest produced by coronary occlusion

Reasons for death in patients successfully resuscitated from out-of-hospital and inhospital cardiac arrest

Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, Interamerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee

the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council

Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers

Cardiac function during mild hypothermia in pigs: increased inotropy at the expense of diastolic dysfunction

Left ventricular function during epinephrine stimulation and hypothermia: effects at spontaneous and paced heart rates in a porcine model

Effects of betaadrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing human left ventricle

Protective effects of therapeutic hypothermia in post-resuscitation myocardium

Prolonged therapeutic hypothermia is more effective in attenuating brain apoptosis in a swine cardiac arrest model

Early initiation of continuous renal replacement therapy induces fast hypothermia and improves post-cardiac arrest syndrome in a porcine model

Impact of myocardial ischemia and reperfusion on ventricular defibrillation patterns, energy requirements, and detection of recovery

A model of ischemically induced ventricular fibrillation for comparison of fixed-dose and escalatingdose defibrillation strategies

Early coronary reperfusion facilitates return of spontaneous circulation and improves cardiovascular outcomes after ischemic cardiac arrest and extracorporeal resuscitation in pigs

Role of epinephrine and extracorporeal membrane oxygenation in the management of ischemic refractory ventricular fibrillation: a randomized trial in pigs

Esmolol for cardioprotection during resuscitation with adrenaline in an ischaemic porcine cardiac arrest model

Comorbidity and survival in out-of-hospital cardiac arrest. Resuscitation

The animals were sedated with midazolam before transportation from the pen to the experimental laboratory

midazolam (0.625 mg/kg; Midazolam, Hameln Pharmaceuticals ltd

Anesthesia was inducted with a dose of ketamine (6.25 mg/kg) and midazolam (0.625 mg/kg)

A single 250 µg fentanyl bolus (Fentanyl, B. Braun, Germany) was administered prior to the surgical procedures to ensure sufficient analgesia. If signs of insufficient sedation (shivering, reflexes, tachycardia, increased ETCO2, decreased SvO2) occurred at any point during the experimental protocol, boluses of propofol (30 mg) and/or remifentanil (300 µg) were administered. If bolus frequency exceeded two per hour, infusion rates of propofol and remifentanil were increased by 25%. If max dosages of anesthetics were insufficient to maintain stable anesthesia a bolus of midazolam (10 mg) was administered

Analysis variability for the dynamic parameters were assessed by Bland-Altman plots and the mean absolute difference for each parameter with 95% confidence intervals were as follows

Serum samples were left to clot for 20 minutes before centrifuged at 4°C and 1,850 G for 9 minutes

The supernatants were stored at -80°C. High sensitivity analysis of troponin-I (TnI) were analyzed by immunochemical reaction

Neuron-specific enolase was measured by an electrochemiluminescent immuno assay (ECLIA)

Plasma samples were centrifuged at 4°C and 1,500 g for 20 minutes immediately after collection and stored at -80°C

ALT) were determined from plasma samples according to standard procedures (Siemens Diagnostics® Clinical Methods for ADVIA 1,800)

Intra-assay variation was in all instances below 3% coefficient of variability and inter-assay variation was below 4% coefficient of variability. 1. Fluid bolus (4 ml/kg) 1.1. Increase in SvO2/CO → repeat 1.2. No effect and/or target not reached →

Start if vasoplegic despite max noradrenaline and normal cardiac output/SvO2

Bolus treatment until effect (bolus size = 0.2 mg, max 1 mg)

Within initial 60 min of ROSC if noradrenaline is insufficient

If MAP <65 mmHg despite max dosage of noradrenaline and terlipressin

Major cardiovascular instability

Ventricular fibrillation/pulseless VT; 3 stacked shocks, 360 J with rhythm checks in between, if no effect start CPR

Asystole/PEA; start CPR as per guidelines, i.e. cycles of 2 min of chest compressions and mechanical ventilation with rhythm check in between and adrenaline and/or amiodarone as recommended

Cardiovascular stable

Persistent ventricular tachycardia (VT); 3 stacked synchronized shocks 360 J with rhythm checks in between, if insufficient or if intermittent VT 300 mg amiodarone i.v. repeated until cardioversion (max 1,200 mg/24 hr). If max dose reached give 1 mg/kg lidocaine and if necessary start cont

Supraventricular tachycardia with hemodynamic instability and/or HR>120; 3 synchronized shocks 360 J, if insufficient 300 mg amiodarone i.v. repeated every hour until cardioversion Amiodarone is administered over 10 min to avoid hypotension

Data S1. Supplemental Methods Table S1 Figures S1-S5 GASTROINTESTINAL Intervention 10 ml/hr enteral nutrition via feeding tube started post-ROSC (equivalent to 3 drops per minute.)